show episodes
 
Artwork
 
340B Insight provides members and supporters of 340B Health with timely updates and discussions about the 340B drug pricing program. The podcast helps listeners stay current with and learn more about 340B to help them serve their patients and communities and remain compliant. We publish new episodes twice a month, with news reports and in-depth interviews with leading health care practitioners, policy and legal experts, public policymakers, and our expert staff.
  continue reading
 
JAMA Health Forum is a peer-reviewed, open-access JAMA Network journal focused on health policy. The journal publishes original research, evidence-based reports, and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity, and reform. The podcast highlights new articles and their authors as well as the latest news in health policy for a broad audience interested in improving health and health c ...
  continue reading
 
Tired of being baffled by healthcare policy? McGuireWoods Consulting presents Complications: Health Policy Unraveled, your solution to the policy puzzle. With our host, Stephanie Kennan, discover the ins and outs of healthcare policy and gain insights crucial for providers and investors. Let's simplify the complex together. Follow us in your favorite podcast app and never miss a healthcare update by subscribing to host and JD Supra’s #1 healthcare author Stephanie Kennan’s Washington Healthc ...
  continue reading
 
Triage: Rapid Legal Lessons for Busy Health Care Professionals has been created by K&L Gates to convey information about developments in health law through short podcasts. If you work in the health care industry, you have grown accustomed to frequent changes in laws and regulations. On some days, it may seem like an insurmountable task to keep up with every change, especially as a new presidential administration and new policies take shape. The K&L Gates Health Care practice will regularly c ...
  continue reading
 
Loading …
show series
 
“The 340B Drug Discount Program is the second largest government pharmaceutical program based on net drug spending and is only behind Medicare Part D. It's been the subject of a lot of legislation and hearings in Congress because of its growth and because of the confusion over contract pharmacies.” In this episode of Complications: Health Policy Un…
  continue reading
 
Senate Appropriations Timing AnnouncedDrug Patent Bill Receives Favorable CBO ScoreSenate Dems Release Bill to Address L&D Unit ClosuresHouse Dems Push Administration to Improve Transparency of ERISA Plan Benefit DenialsCBO Releases Updated Data on 340B SpendingCMS to Discontinue Change Accelerated Payment ProgramFDA Releases Draft Interchangeabili…
  continue reading
 
While significant 340B actions have happened at the federal level, state legislatures also have made big moves in the world of 340B so far this year. We are joined by Amanda Sellers Smith, 340B Health’s legal counsel, to explain more. More states ban drug company restrictions on 340B contract pharmacies Following the lead of Arkansas and Louisiana,…
  continue reading
 
The National Institutes of Health (NIH) has been under scrutiny since COVID-19, so it is not surprising that members of Congress have released NIH reform initiatives. In this episode of Complications: Health Policy Unraveled, host Stephanie Kennan provides a summary of NIH reform recommendations, starting with the white paper released by Republican…
  continue reading
 
SCOTUS Overturns Chevron DoctrineAppropriations UpdateWays & Means Committee Advances Four Health BillsEnergy & Commerce Committee Cancels MarkupLawmakers Urge Oversight of AI in Medicare AdvantageBIOSECURE Receives Favorable CBO ScoreAnalysts Score Impact of Making Permanent Enhanced Affordable Care Act Tax CreditsCMS Issues Proposed Rule on Suspe…
  continue reading
 
The world of 340B has seen significant developments on the state and national levels in recent months. A second federal appeals court decision on 340B contract pharmacies came down in recent weeks, a new bill in Congress threatens to impose significant restrictions on hospital participation in 340B program, and more states move to protect covered e…
  continue reading
 
More than 50 million adults in the US are eligible to vote but not registered. Alister F. Martin, MD, MPP, of Harvard University, and Katherine McCabe, PhD, of Rutgers University speak with JAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD, about a program to register new voters in health care settings that has e…
  continue reading
 
In 2022, the Supreme Court of the United States heard arguments related to Medicare’s Disproportionate Share Hospital Payments. Now that issue is before the court again. In this episode of Complications: Health Policy Unraveled, host Stephanie Kennan discusses an upcoming SCOTUS case involving hospitals and the Department of Health and Human Servic…
  continue reading
 
House Passes NDAASenate Republicans Block Vote on IVF BillFiscal Year 2025 Appropriations UpdateEnergy & Commerce Committee Advances 13 Health BillsHouse Panel Solicits Feedback on Proposed NIH ReformsNovo Nordisk Executive Agrees to Testify Before HELP CommitteeMedPAC, MACPAC Release June Reports to CongressDEA Telemedicine Regulation Under OMB Re…
  continue reading
 
House Passes First FY 2025 Appropriations BillSenate Republicans Block Vote on Contraception BillSen. Wyden Urges HHS to Strengthen Health Sector CybersecurityDemocrats Press for Release of Mental Health Parity Final RuleGAO Provides Status Update on HHS RecommendationsTexas Congresswoman Announces Cancer DiagnosisMenendez Files to Run as Independe…
  continue reading
 
The finalized 340B administrative dispute resolution (ADR) rule is set to go into effect on June 18 and will create a process to settle certain disputes between covered entities and drug manufacturers. But what should covered entities know about this process before it launches? Jason Reddish, a 340B expert with the Powers Pyles Sutter & Verville he…
  continue reading
 
We're back for another episode centered on medical research here at Howard Brown Health. How does it happen and what are we working on? To learn more about research, visit our website. You can visit medicaltrials.gov to learn more about what medical trials are on-going and if you might qualify.By Howard Brown Health
  continue reading
 
Energy & Commerce Committee Advances Data Privacy BillSenate to Vote on Reproductive Rights LegislationHouse Appropriators Adopt Topline Spending LevelsSenators Urge Strong Support for NIH in FY 2025 AppropriationsFinance Members Drafting Bipartisan GME BillReps. Buchanan, Moore Launch New Preventive Health CaucusSen. Rick Scott to Run for Senate G…
  continue reading
 
Medicaid is complicated. In this episode of Complications: Health Policy Unraveled, host Stephanie Kennan discusses the newly finalized regulations concerning Medicaid, specifically as they pertain to the Managed Care Rule. These new regulations aim to increase transparency and improve access in states' Medicaid programs. Key points discussed inclu…
  continue reading
 
House Appropriators Release Preliminary Top-Line Spending AmountsEnergy & Commerce Subcommittee Advances 21 Health Care BillsHouse BIOSECURE Bill Advances Out of CommitteeFAA Reauthorization Includes Possible Change to Organ Transportation Policy, Updates to In-Flight Emergency Medical KitsFinance Committee Leaders Release White Paper on Physician …
  continue reading
 
The Center for Medicaid & Medicare Services (CMS) recently released new guidelines that will affect the Medicare drug price negotiation process beginning in 2026. In this episode of Complications: Health Policy Unraveled, host Stephanie Kennan provides a summary of the new CMS guidelines, including the new requirements for drug manufacturers and Pa…
  continue reading
 
Hospitals throughout the U.S. use their 340B savings in innovative ways to care for their patients in need. In some cases, they can take that care outside the walls of the hospital to meet patients where they learn, live, and play. We speak with Heather Armstrong with Comanche County Medical Center in central Texas to tell us how her health system …
  continue reading
 
House Speaker Mike Johnson Survives Motion to VacateWays and Means Committee Marks Up Telehealth, Rural Health Legislation Sen. Marshall Previews Reintroduction of Prior Authorization BillRep. Comer Urges Use of Spending Bills to Gain Compliance with Oversight RequestsEnergy & Commerce Committee Republicans Question ASPR’s Management of SNSReps. Bl…
  continue reading
 
Reps. Greene, Massie to Trigger Motion to Vacate VoteHouse Passes Congressional Budget Office Data Sharing ActSenate Passes Minority Health Resolution, Considers Health Professional ShortagesSenate Finance Leaders Release Proposal Aimed at Drug ShortagesWays and Means Expected to Markup Telehealth LegislationSen. Klobuchar Requests Investigation in…
  continue reading
 
JAMA Health Forum Editor John Ayanian, MD, MPP, speaks with Kelsey M. Owsley, PhD, of the University of Arkansas, and Sayeh Nikay, PhD, MPH, of the University of Minnesota, about how the 340B drug discount program influences the services offered by public and nonprofit hospitals. They also discuss new state policies and proposed federal policies to…
  continue reading
 
Recently, some consumers have found that their health plans had been changed without their knowledge, impacting their coverage and their finances. In this episode of Complications: Health Policy Unraveled, host Stephanie Kennan explores unauthorized plan switching related to Affordable Care Act health plans. Consumers are being unknowingly switched…
  continue reading
 
Take a deep dive with us about the 340B Federal Funding Program, what it does, why it matters, and how our Diabetes Care Team navigate it! Find your elected officials here. Learn more about the Diabetes Care Team here. Learn about the Center for Education, Research, and Advocacy.By Howard Brown Health
  continue reading
 
340B savings can help hospitals and other covered entities better serve patients and improve their health outcomes. But how can these entities make the best use of 340B funds for their institutions? We sat down with Matt Webber, director of pharmacy business at Novant Health based in North Carolina, to learn more. 340B optimization strategies One w…
  continue reading
 
The Congressional Review Act has been used to overturn 20 rules since it was enacted. Will a Biden administration healthcare rule be next? In this episode of Complications: Health Policy Unraveled, host Stephanie Kennan explores the intricacies of the Congressional Review Act (CRA) and its significance for healthcare policy. She explains how the CR…
  continue reading
 
Energy & Commerce Schedules Hearing on Change Healthcare CyberattackSen. Cassidy Questions FDA Oversight of Clinical Decision Support SoftwareRep. Buchanan Asks MedPAC to Rethink Approach to Digital Health ToolsDemocratic Senators Raise Concerns With Levemir DiscontinuationGAO Releases New Report on State PBM RegulationsCBO Releases Analysis of Med…
  continue reading
 
The 340B community has seen major activity on several fronts since the start of 2024 – the introduction of new legislation on Capitol Hill, movement on legislation in the states, and key developments in the courts. 340B Health President and CEO Maureen Testoni returns to the show to help us make sense of these developments and how they might affect…
  continue reading
 
In this two-part Triage series, Gina Bertolini, Stephen Page, and Sarah Staples-Carlton discuss an old health care regulatory doctrine that has new relevance in a post-COVID world, where the delivery of care via telemedicine and other remote models has become heavily adopted: Corporate Practice of Medicine, or “CPOM.” As more and more health care c…
  continue reading
 
Bipartisan Privacy Rights Draft ReleasedRep. Aderholt Presses for Budget Reforms Before Vote on New Appropriations LeaderCMS Finalizes 2025 MA Payment UpdateHHS Releases Drug Shortages White PaperHSGAC Chairman Seeks Information on Private Equity Impact on ER CareE&C GOP Requests GAO Report on NIH Handling of National Security ConcernsRep. Grijalva…
  continue reading
 
Benjamin D. Sommers, MD, PhD, of Harvard University, speaks with JAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD, about differences in Medicaid enrollment as measured in surveys and administrative data. These differences have implications for estimating coverage now that the federal policy of continuous Medicai…
  continue reading
 
Congress has a number of important healthcare issues currently pending, but whether any get resolved before the end of the term is still to be seen. In this episode of Complications: Health Policy Unraveled, Stephanie Kennan explores key healthcare policy issues before Congress, including PBM reform, healthcare transparency, cybersecurity, insulin …
  continue reading
 
In this two-part Triage series, Gina Bertolini, Sarah Carlins, and Jianne McDonald analyze two recent HHS initiatives that address cybersecurity risks to hospitals and health systems nationwide. Cybersecurity events involving our nation’s health care providers have precipitously risen in the past five years. The Department of Health and Human Servi…
  continue reading
 
In this two-part Triage series, Gina Bertolini, Sarah Carlins, and Jianne McDonald analyze two recent HHS initiatives that address cybersecurity risks to hospitals and health systems nationwide. Cybersecurity events involving our nation’s health care providers have precipitously risen in the past five years. The Department of Health and Human Servi…
  continue reading
 
One of the most important elements of 340B compliance is preventing duplicate discounts. Ensuring there are no duplicate discounts is high on the list of compliance concerns for covered entities, and it is one of the major items that 340B auditors look for. But how do these entities ensure they stay compliant? On this episode, we speak to Melissa B…
  continue reading
 
Congress Wraps Up FY2024 AppropriationsHouse Passes Preventive Health Savings ActEnergy & Commerce Advances 17 Health BillsDemocrats Push CFPB to Revise Handling of Medical DebtSens. Warren, Rubio Press DoD on Pharmaceutical Supply ChainBipartisan Investigation into High-Risk Research AnnouncedSenate Dems Comment on Pandemic Accord NegotiationsCong…
  continue reading
 
Artificial intelligence continues to be a focus for Congress and federal agencies. Are you keeping up with the latest developments that impact the healthcare sector? In episode 22 of Complications: Health Policy Unraveled, host Stephanie Kennan provides updates on legislative and regulatory affairs concerning artificial intelligence. With the forma…
  continue reading
 
President Biden Releases FY 2025 Budget ProposalHHS FY 2024 Funding Deadline ApproachesSen. Lankford Blocks VA IVF LegislationEnergy & Commerce Health Sub Advances 19 BillsSen. Hassan Urges UnitedHealth to Better Support Providers Impacted by CyberattackFinance, HELP Committee Leadership Push Agencies to Address Surprise Patient Costs Sen. Cassidy …
  continue reading
 
***A previous version of this podcast stated that Sen. Bob Menendez had announced his retirement. We regret the error.***President Biden Delivers State of the Union AddressGovernment Funding Package Signed With Medicare Physician Payment ProvisionCMS Announces Advanced Payments in Response to Clearinghouse CyberattackHouse Passes Seven Health Bills…
  continue reading
 
340B hospitals can register certain outpatient locations with the Health Resources & Services Administration (HRSA) as 340B child sites, which allows them to use 340B drugs. HRSA recently announced some changes to how it had been determining this eligibility during the COVID-19 public health emergency. How have these changes affected 340B hospitals…
  continue reading
 
What does fishing have to do with healthcare? Currently before SCOTUS is Loper Bright Enterprises, a case involving federal oversight of herring fishing which could impact the government's regulatory power broadly and thus, the healthcare sector. In episode 21 of Complications: Health Policy Unraveled, host Stephanie Kennan explores Loper Bright En…
  continue reading
 
In this episode, Rebecca Schaefer, Michael Hinckle, and Elisabeth Lewis summarize FDA regulatory developments from 2023 and what to expect in 2024 as it relates to clinical research. They discuss the significance of the decentralized clinical trials guidance documents, highlights of the Informed Consent Guidance document, the impacts of FDA’s final…
  continue reading
 
Congress Extends Government FundingCongress Reaches Deal on Six Appropriations Bills and Health ProvisionsHouse to Vote on Health Bills This WeekSen. Mitch McConnell to Step Down from Senate LeadershipLawmakers Respond to Alabama Embryo RulingSen. Grassley Releases Updates on FTC’s PBM InvestigationAI Work Group Considers Role of Medicare/Medicaid …
  continue reading
 
JAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD, speak with Rachel A. Prusynski, DPT, PhD, of the University of Washington about differences in the use and outcomes of home health services provided to beneficiaries in traditional Medicare and Medicare Advantage. Related Content: Differences in Home Health Servi…
  continue reading
 
The Health Resources & Services Administration audits 200 covered entities each year for compliance with 340B rules. We speak with Mark Capuano, senior director of the corporate pharmacy 340B program at New York City Health and Hospitals, about what hospitals should expect when they find out they will be going through a 340B audit. How a hospital c…
  continue reading
 
Senate Passes Supplemental Appropriations MeasureLawmakers Consider Potential of Short and Long-Term Physician Fee Schedule ReformSens. Durbin, Braun Call on FDA to Address Rx Drug Promotion on Social MediaEnergy & Commerce Leaders Ask GAO to Assess Risks of Selling Excess Laboratory EquipmentSanders Urges Strong Warning Labels to Combat Diabetes E…
  continue reading
 
340B sits at an intersection where federal programs and state agencies come together. Maine, Minnesota, and Washington recently enacted new laws requiring hospitals to report 340B information to the states each year. What should health systems know about these new requirements? We speak with Danny Ackert, the director of state government relations …
  continue reading
 
Loading …

Quick Reference Guide